PHA-848125AC
Drug timelines are a Plus or Pro feature.
3 regulatory and trial events tracked for PHA-848125AC, covering 2011-02-21 to 2018-10-16. Get the full timeline:
Most recent: Clinical Trial Update: Phase II Study Of Oral PHA-848125AC In Patients With Thymic Carcinoma [Phase 2]